Last update 21 Nov 2024
Fenticonazole nitrate/lidocaine/tinidazole
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms EVEGYN |
Target |
Mechanism DNA modulators(DNA modulators), Ergosterol biosynthesis inhibitors, SCNA modulators(Sodium channel alpha subunit modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC8H13N3O4S |
InChIKeyHJLSLZFTEKNLFI-UHFFFAOYSA-N |
CAS Registry19387-91-8 |
View All Structures (3)
Related
2
Clinical Trials associated with Fenticonazole nitrate/lidocaine/tinidazoleA Single Center, Single Arm, Single Dose, Bioavailability Study of EVEGYN 600 mg/1000 mg/100 mg Vaginal Ovule (a Fixed Dose Combination of 600 mg Fenticonazole Nitrate + 1000 mg Tinidazole + 100 mg Lidocaine) in 18 Healthy Female Subjects
Phase III Study to Evaluate Efficacy and Safety of Different Formulations of Fenticonazole + Tinidazole + Lidocaine in the Treatment of Bacterial Vaginosis, Candidal Vulvovaginitis, Trichomonal Vaginitis and Mixed Infections
100 Clinical Results associated with Fenticonazole nitrate/lidocaine/tinidazole
Login to view more data
100 Translational Medicine associated with Fenticonazole nitrate/lidocaine/tinidazole
Login to view more data
100 Patents (Medical) associated with Fenticonazole nitrate/lidocaine/tinidazole
Login to view more data
100 Deals associated with Fenticonazole nitrate/lidocaine/tinidazole
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Bacterial Vaginosis | Phase 3 | TR | 28 Sep 2023 | |
| Candidiasis, Vulvovaginal | Phase 3 | TR | 28 Sep 2023 | |
| Infective vaginitis | Phase 3 | TR | 28 Sep 2023 | |
| Trichomonas Vaginitis | Phase 3 | TR | 28 Sep 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free